Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
The present invention relates to a melanin concentrating hormone antagonist compound of formula I: (I); or a pharmaceutically acceptable salt, solvate, enantiomer or prodrug thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and related diseases.
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | AMMENN JOCHEN SLIEKER LAWRENCE JOHN SNYDER NANCY JUNE ROBERTSON MICHAEL ALAN KINNICK MICHAEL DEAN MORIN, JR. JOHN MICHAEL GILLIG JAMES RONALD SAVIN KENNETH ALLEN SCHOTTEN THEO HEINZ LAWRENCE JOSEPH LAI YEN-SHI OTT CARSTEN HIPSKIND PHILIP ARTHUR NIXON JAMES ARTHUR |
description | The present invention relates to a melanin concentrating hormone antagonist compound of formula I: (I); or a pharmaceutically acceptable salt, solvate, enantiomer or prodrug thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and related diseases. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US7229987B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US7229987B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US7229987B23</originalsourceid><addsrcrecordid>eNqNzTEOwjAMheEuDAi4gy_AUobSFQRiYQLmyk3dNlJiR7E79PZk4ABMb_g_6W0rfS7BvFtd8A6cxCQLDwqjZFiUABUiBWTPJbIjtozmeYJZchQugA0nYa-mUJDNBJYJLRYKMoL0pN7W4gYYPPZkpPtqM2JQOvx2V8H99r4-jpSkI01Yfsi6z6up67Y9N5f69Af5AjFKRRA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes</title><source>esp@cenet</source><creator>AMMENN JOCHEN ; SLIEKER LAWRENCE JOHN ; SNYDER NANCY JUNE ; ROBERTSON MICHAEL ALAN ; KINNICK MICHAEL DEAN ; MORIN, JR. JOHN MICHAEL ; GILLIG JAMES RONALD ; SAVIN KENNETH ALLEN ; SCHOTTEN THEO ; HEINZ LAWRENCE JOSEPH ; LAI YEN-SHI ; OTT CARSTEN ; HIPSKIND PHILIP ARTHUR ; NIXON JAMES ARTHUR</creator><creatorcontrib>AMMENN JOCHEN ; SLIEKER LAWRENCE JOHN ; SNYDER NANCY JUNE ; ROBERTSON MICHAEL ALAN ; KINNICK MICHAEL DEAN ; MORIN, JR. JOHN MICHAEL ; GILLIG JAMES RONALD ; SAVIN KENNETH ALLEN ; SCHOTTEN THEO ; HEINZ LAWRENCE JOSEPH ; LAI YEN-SHI ; OTT CARSTEN ; HIPSKIND PHILIP ARTHUR ; NIXON JAMES ARTHUR</creatorcontrib><description>The present invention relates to a melanin concentrating hormone antagonist compound of formula I: (I); or a pharmaceutically acceptable salt, solvate, enantiomer or prodrug thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and related diseases.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070612&DB=EPODOC&CC=US&NR=7229987B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76419</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070612&DB=EPODOC&CC=US&NR=7229987B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>AMMENN JOCHEN</creatorcontrib><creatorcontrib>SLIEKER LAWRENCE JOHN</creatorcontrib><creatorcontrib>SNYDER NANCY JUNE</creatorcontrib><creatorcontrib>ROBERTSON MICHAEL ALAN</creatorcontrib><creatorcontrib>KINNICK MICHAEL DEAN</creatorcontrib><creatorcontrib>MORIN, JR. JOHN MICHAEL</creatorcontrib><creatorcontrib>GILLIG JAMES RONALD</creatorcontrib><creatorcontrib>SAVIN KENNETH ALLEN</creatorcontrib><creatorcontrib>SCHOTTEN THEO</creatorcontrib><creatorcontrib>HEINZ LAWRENCE JOSEPH</creatorcontrib><creatorcontrib>LAI YEN-SHI</creatorcontrib><creatorcontrib>OTT CARSTEN</creatorcontrib><creatorcontrib>HIPSKIND PHILIP ARTHUR</creatorcontrib><creatorcontrib>NIXON JAMES ARTHUR</creatorcontrib><title>Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes</title><description>The present invention relates to a melanin concentrating hormone antagonist compound of formula I: (I); or a pharmaceutically acceptable salt, solvate, enantiomer or prodrug thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and related diseases.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNzTEOwjAMheEuDAi4gy_AUobSFQRiYQLmyk3dNlJiR7E79PZk4ABMb_g_6W0rfS7BvFtd8A6cxCQLDwqjZFiUABUiBWTPJbIjtozmeYJZchQugA0nYa-mUJDNBJYJLRYKMoL0pN7W4gYYPPZkpPtqM2JQOvx2V8H99r4-jpSkI01Yfsi6z6up67Y9N5f69Af5AjFKRRA</recordid><startdate>20070612</startdate><enddate>20070612</enddate><creator>AMMENN JOCHEN</creator><creator>SLIEKER LAWRENCE JOHN</creator><creator>SNYDER NANCY JUNE</creator><creator>ROBERTSON MICHAEL ALAN</creator><creator>KINNICK MICHAEL DEAN</creator><creator>MORIN, JR. JOHN MICHAEL</creator><creator>GILLIG JAMES RONALD</creator><creator>SAVIN KENNETH ALLEN</creator><creator>SCHOTTEN THEO</creator><creator>HEINZ LAWRENCE JOSEPH</creator><creator>LAI YEN-SHI</creator><creator>OTT CARSTEN</creator><creator>HIPSKIND PHILIP ARTHUR</creator><creator>NIXON JAMES ARTHUR</creator><scope>EVB</scope></search><sort><creationdate>20070612</creationdate><title>Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes</title><author>AMMENN JOCHEN ; SLIEKER LAWRENCE JOHN ; SNYDER NANCY JUNE ; ROBERTSON MICHAEL ALAN ; KINNICK MICHAEL DEAN ; MORIN, JR. JOHN MICHAEL ; GILLIG JAMES RONALD ; SAVIN KENNETH ALLEN ; SCHOTTEN THEO ; HEINZ LAWRENCE JOSEPH ; LAI YEN-SHI ; OTT CARSTEN ; HIPSKIND PHILIP ARTHUR ; NIXON JAMES ARTHUR</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US7229987B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2007</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>AMMENN JOCHEN</creatorcontrib><creatorcontrib>SLIEKER LAWRENCE JOHN</creatorcontrib><creatorcontrib>SNYDER NANCY JUNE</creatorcontrib><creatorcontrib>ROBERTSON MICHAEL ALAN</creatorcontrib><creatorcontrib>KINNICK MICHAEL DEAN</creatorcontrib><creatorcontrib>MORIN, JR. JOHN MICHAEL</creatorcontrib><creatorcontrib>GILLIG JAMES RONALD</creatorcontrib><creatorcontrib>SAVIN KENNETH ALLEN</creatorcontrib><creatorcontrib>SCHOTTEN THEO</creatorcontrib><creatorcontrib>HEINZ LAWRENCE JOSEPH</creatorcontrib><creatorcontrib>LAI YEN-SHI</creatorcontrib><creatorcontrib>OTT CARSTEN</creatorcontrib><creatorcontrib>HIPSKIND PHILIP ARTHUR</creatorcontrib><creatorcontrib>NIXON JAMES ARTHUR</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>AMMENN JOCHEN</au><au>SLIEKER LAWRENCE JOHN</au><au>SNYDER NANCY JUNE</au><au>ROBERTSON MICHAEL ALAN</au><au>KINNICK MICHAEL DEAN</au><au>MORIN, JR. JOHN MICHAEL</au><au>GILLIG JAMES RONALD</au><au>SAVIN KENNETH ALLEN</au><au>SCHOTTEN THEO</au><au>HEINZ LAWRENCE JOSEPH</au><au>LAI YEN-SHI</au><au>OTT CARSTEN</au><au>HIPSKIND PHILIP ARTHUR</au><au>NIXON JAMES ARTHUR</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes</title><date>2007-06-12</date><risdate>2007</risdate><abstract>The present invention relates to a melanin concentrating hormone antagonist compound of formula I: (I); or a pharmaceutically acceptable salt, solvate, enantiomer or prodrug thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and related diseases.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_US7229987B2 |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T00%3A03%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=AMMENN%20JOCHEN&rft.date=2007-06-12&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS7229987B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |